TABLE 3.
Summary of the cases with nasal bone abnormality identified with pathogenic/likely pathogenic CNVs by genetic amiocentesis (n = 19).
Case | MA (y) | GA (w) | Other ultrasonic findings | Aneuploidy | Copy number variations | Classifi-cation | Outcomes |
---|---|---|---|---|---|---|---|
Screening | |||||||
1 | 28 | 27 | None | cfDNA: LR | arr [GRCh37] 16p13.3 (3694760_4299989)x3 | P | TOP |
2 | 27 | 26 | echoless midline brain, flat facial shape, micrognathia | cfDNA: LR | arr [GRCh37] 4p16.3p15.1 (68346_33755417)x1 | P | TOP |
thoracolumbar scoliosis, abnormal left foot posture and SUA | |||||||
3 | 30 | 27 | SUA | MSS: LR | arr [CRCh37] 11q13.4q25 (72744004_134937416)x3 | P | TOP |
4 | 26 | 23 | SUA | cfDNA: LR | arr [CRCh37] 1q44 (243943235_249224684)x1 | P | TOP |
5 | 29 | 23 | TCD < −3SD, SUA | cfDNA: LR | arr [GRCh37] 5p15.33p14.1 (113576_25370521)x1 | P | TOP |
arr [GRCh37] 9p24.3p21.3 (208454_20653331)x3 | P | ||||||
6 | 31 | 17 | reversed a-wave in fetal ductus venosus | None | arr [GRCh37] 22q13.1q13.33 (38789935_51197766)x3 | P | TOP |
7 | 29 | 29 | PLSVC | MSS: HR | arr [GRCh37] 19p13.2 (9736153_12602337)x1 | P | TOP |
8 | 27 | 23 | None | cfDNA: LR | arr [GRCh37] 13q13.2q34 (35235990_115107733)x1-2 | P | NLB, follow-up to 8 months showed no abnormality |
9 | 29 | 27 | None | cfDNA: LR | arr [GRCh37] 9p24.3p13.1 (208454_38772005)x3 | P | TOP |
10 | 29 | 24 | bilateral superior vena cava, ductus venosus agenesis, enlarged inferior vena cava, enlarged right heart, pericardial effusion | MSS: LR | arr [GRCh37] 22q11.21 (18648856_21800471)x1 | P | TOP |
11 | 36 | 18 | None | cfDNA: LR | arr [GRCh37] 9q31.2q33.2 (110873766_125177344)x1 | P | TOP |
12 | 32 | 18 | NT 4.8 mm | None | arr [GRCh37] 16p11.2 (29428532_30176508)x1 | LP | TOP |
13 | 32 | 18 | None | None | arr [GRCh37] 16p11.2 (28748617_29051191)x1 | LP | TOP |
14 | 30 | 27 | polyhydramnios | cfDNA: LR | arr [GRCh37] 16p11.2 (29428532_30178406)x3 | LP | NLB, follow-up to 24 months showed no abnormality |
15 | 29 | 25 | echogenic intracardiac focus, left aortic arch, aberrant right subclavian artery | MSS: LR | arr [CRCh37] 1q44 (224817841_246711631)x1 | LP | Postnatal death |
16 | 32 | 19 | thickened NF, cystic hygroma of the neck, VSD | None | arr [CRCh37] 10q24.31q24.32 (102979827_103370322)x3 | LP | TOP |
17 | 38 | 26 | polyhydramnios | cfDNA: LR | arr [GRCh37] 17p12 (14060292_15484335)x1 | LP | NLB, follow-up to 7 months showed no abnormality |
18 | 30 | 26 | None | cfDNA: LR | arr [GRCh37] 17p12 (14060292_15513053)x1 | LP | TOP |
19 | 30 | 17 | None | None | arr [CRCh37]1q21.1q21.2 (145390102_147844778)x3 | LP | NLB, follow-up to 9 months with asymptomatic ASD |
MA, maternal age; GA, gestational age; MSS, maternal serological screening; NT, nuchal translucency; cfDNA, cell-free DNA; LR, low risk; HR, high risk; SUA, single umbilical artery; PLSVC, permanent left superior vena cava; TCD, transverse cerebellum diameter; NF, nuchal fold; VSD, ventricular septal defect; ASD, atrial septal defect; ARSA, aberrant right subclavian artery; P, pathogenic; LP, likely pathogenic; TOP, termination of pregnancy; NLB, normal life birth.